Liver transplantation in congenital disorders of glycosylation: A systematic review
Journal of Pediatric Gastroenterology and Nutrition · 10.11.2026
DOI: 10.1002/jpn3.70657 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 10.11.2026. Verfasst von Patryk Lipiński und 1 weiteren Autor:innen. Beteiligte Einrichtung: Third Department of Pediatrics, Center of Postgraduate Medical Education, Dziekanów Leśny, Poland. Die Arbeit nennt 19 Literaturangaben. Gefördert von: None.
Abstract (Originalsprache)
Objectives
To synthesize patient‐level evidence on indications, immunosuppression, outcomes, and residual extrahepatic disease after liver transplantation (LTx) in congenital disorders of glycosylation (CDG).
Methods
PubMed/MEDLINE was searched from inception to July 5, 2026, supplemented by backward and forward citation searching. Two reviewers independently screened records and full‐text reports, linked duplicate patient descriptions, extracted data, and appraised reporting quality. Case reports and series providing individual‐level LTx data were eligible. Owing to clinical heterogeneity, results were synthesized descriptively.
Results
The searches yielded 42 records (PubMed/MEDLINE, n = 33; citation searching, n = 9). After removal of eight duplicate records, 34 unique records were screened; 25 were excluded by title and abstract. Nine full‐text reports were assessed and all met the eligibility criteria. These publications described at least 12 distinct recipients with ATP6AP1‐CDG ( n = 5), PMM2‐CDG ( n = 2), CCDC115‐CDG ( n = 2), MPI‐CDG ( n = 1), COG6‐CDG ( n = 1), or ATP6AP2‐CDG ( n = 1). Age at first LTx ranged from 7 months to 28 years. Ten of 12 recipients (83.3%) were alive with a functioning graft at the latest reported assessment, although formal actuarial patient and graft survival could not be calculated. Successful LTx generally corrected hepatic synthetic dysfunction and liver‐derived glycoprotein abnormalities, but immune, neurological, and pancreatic manifestations persisted.
Conclusions
LTx can rescue severe hepatic disease and provide liver‐specific metabolic correction in selected CDG, but it should not be considered a systemic cure. Candidate selection and immunosuppression require multidisciplinary, genotype‐informed assessment. Prospective standardized reporting is needed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Third Department of Pediatrics, Center of Postgraduate Medical Education, Dziekanów Leśny, Poland.
- Department of Gastroenterology, Hepatology, Feeding Disorders and Pediatrics, The Children's Memorial Health Institute, Warsaw, Poland.
ORCID-Profile: Patryk Lipiński, Piotr Socha
Förderung
- None
Zitieren
APA
Lipiński, P., & Socha, P. (2026). Liver transplantation in congenital disorders of glycosylation: A systematic review. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70657
Vancouver
Lipiński P, Socha P. Liver transplantation in congenital disorders of glycosylation: A systematic review. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70657
BibTeX
@article{Lipiski2026,
author = {Lipiński, Patryk and Socha, Piotr},
title = {Liver transplantation in congenital disorders of glycosylation: A systematic review},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2026},
doi = {10.1002/jpn3.70657}
}
EUVIMED